Literature DB >> 19698995

A longitudinal study of cognitive function in melancholic and non-melancholic subtypes of major depressive disorder.

Adrienne Withall1, Lynne M Harris, Steven R Cumming.   

Abstract

BACKGROUND: Research concerning cognition in depression has often yielded inconsistent findings. The presence of mixed melancholic and non-melancholic subtypes of major depressive disorder (MDD) in most previous research may explain some of the contradictory results (Hickie, 1996).
METHODS: This longitudinal study compared the cognitive performance of people with melancholic (n=17) and non-melancholic (n=17) MDD admitted to one of two university hospitals. Participants received an extensive clinical and cognitive assessment at admission and again 3 months after recovery and discharge.
RESULTS: Overall, participants with melancholia had selective memory deficits with broader impairment of executive control skills. Specifically, after correcting for depression severity, they performed more poorly on tests requiring memory acquisition, mental flexibility, set-shifting, selective attention, concept-formation and multi-tasking compared to those with non-melancholic depression. These deficits were present at both assessments suggesting that the increased initial severity of cognitive deficits for those with melancholia mean that they require a longer time to recovery. LIMITATIONS: The clinical homogeneity of the study sample may underestimate the extent of cognitive impairment for those presenting with comorbid illness and/or significant drug/alcohol histories.
CONCLUSIONS: These findings indicate that the depressed group with melancholia have a distinctly different and more impaired cognitive profile to those without melancholic features and suggest that these clinical subtypes should be considered separately in future research concerning MDD. Furthermore, the melancholic group appears to require longer periods for cognitive recovery and this has implications for return to work and daily functioning following clinical discharge. Crown Copyright 2009. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19698995     DOI: 10.1016/j.jad.2009.07.012

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  19 in total

Review 1.  Specifying the neuropsychology of affective disorders: clinical, demographic and neurobiological factors.

Authors:  Thomas Beblo; Grant Sinnamon; Bernhard T Baune
Journal:  Neuropsychol Rev       Date:  2011-06-10       Impact factor: 7.444

2.  Psychiatric symptom versus neurocognitive correlates of diminished expressivity in schizophrenia and mood disorders.

Authors:  Alex S Cohen; Yunjung Kim; Gina M Najolia
Journal:  Schizophr Res       Date:  2013-03-06       Impact factor: 4.939

3.  Luria's three-step test: what is it and what does it tell us?

Authors:  Myron F Weiner; Linda S Hynan; Heidi Rossetti; Jed Falkowski
Journal:  Int Psychogeriatr       Date:  2011-05-04       Impact factor: 3.878

4.  Melancholic versus non-melancholic depression: differences on cognitive function. A longitudinal study protocol.

Authors:  Saray Monzón; Margalida Gili; Margalida Vives; Maria Jesus Serrano; Natalia Bauza; Rosa Molina; Mauro García-Toro; Joan Salvà; Joan Llobera; Miquel Roca
Journal:  BMC Psychiatry       Date:  2010-06-17       Impact factor: 3.630

5.  [Verbal memory in patients with major depression].

Authors:  S Mörkl; A Painold; H-P Kapfhammer; A K Holl
Journal:  Nervenarzt       Date:  2014-09       Impact factor: 1.214

Review 6.  Cognitive dysfunction in major depressive disorder: effects on psychosocial functioning and implications for treatment.

Authors:  Raymond W Lam; Sidney H Kennedy; Roger S Mclntyre; Atul Khullar
Journal:  Can J Psychiatry       Date:  2014-12       Impact factor: 4.356

7.  Clinical subtypes of depression are associated with specific metabolic parameters and circadian endocrine profiles in women: the power study.

Authors:  Giovanni Cizza; Donna S Ronsaville; Hayley Kleitz; Farideh Eskandari; Sejal Mistry; Sara Torvik; Nina Sonbolian; James C Reynolds; Marc R Blackman; Philip W Gold; Pedro E Martinez
Journal:  PLoS One       Date:  2012-01-03       Impact factor: 3.240

Review 8.  Cognitive Dysfunction in Major Depressive Disorder. A Translational Review in Animal Models of the Disease.

Authors:  Flavie Darcet; Alain M Gardier; Raphael Gaillard; Denis J David; Jean-Philippe Guilloux
Journal:  Pharmaceuticals (Basel)       Date:  2016-02-17

9.  Association between vitamin b12 levels and melancholic depressive symptoms: a Finnish population-based study.

Authors:  Jussi Seppälä; Hannu Koponen; Hannu Kautiainen; Johan G Eriksson; Olli Kampman; Jaana Leiviskä; Satu Männistö; Pekka Mäntyselkä; Heikki Oksa; Yrjö Ovaskainen; Merja Viikki; Mauno Vanhala; Jussi Seppälä
Journal:  BMC Psychiatry       Date:  2013-05-24       Impact factor: 3.630

10.  Cognitive Deficits as a Mediator of Poor Occupational Function in Remitted Major Depressive Disorder Patients.

Authors:  Young Sup Woo; Joshua D Rosenblat; Ron Kakar; Won-Myong Bahk; Roger S McIntyre
Journal:  Clin Psychopharmacol Neurosci       Date:  2016-02-29       Impact factor: 2.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.